Sex Differences in Lung Cancer Treatment and Outcomes at a Large Hybrid Academic-Community Practice.

JTO Clin Res Rep · 2022 · PMC8983352 · PMID 35400080

Europe PMC DOI

hedged sentence

0.0700

closest p · 1.4× alpha

0.0700

boldest claim

The sentences

did not reach statistical significancep = 0.07so close (0.05 < p ≤ 0.1)

Although there were higher rates of SCLC among females (13.8% versus 11.8%), this did not reach statistical significance ( p = 0.07), whereas for histologic subtype, females were more likely to have adenocarcinoma (74.2% versus 62.4 % for males, p < 0.001).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.